Genscript Biotech's Wild Ride: Is the Market Overlooking a Hidden Gem?
Recent volatility in Genscript Biotech's (SEHK:1548) share price has investors questioning its true worth. While short-term gains offer a glimmer, a deeper look reveals a stark three-year decline, setting the stage for a critical valuation debate.